Resistance to dermatophyte fungi depends on both non-specific and specific immunological mechanisms.
The importance of following these changes which develop in response to a foreign antigen is that the epidermis is "switched on", a feature which helps localize the need for of f ector cells at one particular skin site and where it is possible to reactivate the system at some later event1). Skin invasion by dermatophytes involves the production of proteases which are inducible in the presence of amino acid residues12). While at least three low molecular weight proteases have been isolated from T. mentagrophytes13), a number of different proteases have been described for T. rubrum. These range from 34, 77 and 105 kD moieties. In addition this dermatophyte produces a secreted metalloprotease with a molecular weight of c 200 kD which shows specificity for collagen and elastin (Lambkin, Hamilton and Hay-unpubished data).
Immunity to infection
Human dermatophyte infections can be classified as acute or chronic; acute infections in man are often caused by zoophilic fungi, chronic by anthropophilic organisms. Defence against dermatophytes depends on the activation of both immune and non-immune mechanisms. The principle pathways are unsaturated transferrin, migration of polymorphonuclear leucocytes into the area of infection and T lymphocyte activation2). No work has identified an iron receptor in dermatophyte fungi, although siderophores are known in a variety of plant pathogens such as Alternaria species. Unfortunately there has been little work on the so called nonspecific mechanisms of defence against dermatophytosis.
Generally the fungi are inhibited by a number of different ways. Unsaturated transferrin inhibits the growth of dermatophytes by a direct mechanism involving binding to the fungal membrane14). The speed of growth of the epidermis is also increased in human dermatophytosis; a similar phenomenon has been shown in experimental candidosis in guinea pigs2) and experimental dermatophytosis in mice. In these experimental infections increased epidermal proliferation occurs early in the infection, within 48 hours in mice, in other words before classical immunological activation can have occurred.
Likewise
The former are important components of the histological response to hair follicle invasion in man and animals. Human PMN have been shown to destroy up to 60% of T. rubrum and T. quinckeanum germlings within two hours; macrophages kill up to 20% in a similar time. PMN killing is enhanced by concanavalin-A or phorbol myristate acetate17). The effects of PMN's have been reproduced by an in vitro system using lactoperoxidase, hydrogen peroxidase and potassium iodide and can be abrogated with catalase, superoxide dismutase and histidine which are known scavengers of hydrogen peroxide, superoxide anion and singlet oxygen respectively17). Killing can proceed even in the absence of ingestion of fungal hyphae by neutrophils. The existence of a second type of phagocyte mediated defence as occurs with Candida via a peptide mechanism for dermatophytes has not been discovered. Trichophyton rubrum produces a catalase which may affect the outcome of phagocyte mediated defence16).
Neutrophils are attracted to the site of infection both by production of epidermally derived chemotactic factors such as leukotriene derivatives and also by certain dermatophyte cell wall antigens which activate the alternate pathway of complement18, 19)
Susceptibility and immunomodulation
Previous studies have occasionally revealed a number of underlying diseases in patients with dermatophytosis notably hereditary palmoplantar keratoderma20) and Raynaud's phenomenon. A high proportion, over 40% in some surveys, are atopic on personal or family history21). Patients with chronic mucocutaneous candidosis (CMC) are also particularly susceptible to widespread intractable dermatophytosis as well as candidosis;
human immunodeficiency virus (HIV) infected individuals may also have chronic ringworm. These studies suggest that patients with impairment of immunological defence mechanisms, in particular those affecting T lymphocyte function are prone to chronic infection. However in all these examples whereas the clinical expression of infection may be modified by the patients' underlying condition the prevalence of dermatophytosis in compromised patients is not significantly different to that seen in healthy subjects. In AIDS patients the prevalence of infection is no higher than in members of "at risk" groups without HIV infection 22). Also, with the exception of atopy, underlying disease is not seen in the majority of patients with dermatophytosis23).
With infections due to C. albicans the picture is more confusing as two main groups of predisposed subjects are affected by this opportunistic pathogenthose with abnormalities of neutrophil or T lymphocyte function. However, individuals in the latter category, including patients with CMC and AIDS, usually have chronic cutaneous or oropharyngeal rather than systemic infections. Patients with CMC are also susceptible to dermatophytosis.
In experimental murine infections transfer of T lymphocytes bearing the Thy-1 helper phenotype is the key event in determining immunity. During primary infection in mice there is evidence of polyclonal suppression of lymphocyte activation during the phase of activation of lymphocytes reactive to dermatophyte antigens 24). Immunity to infection can be transferred to irradiated naive animals with lymphocytes bearing the Thy-1 phenotype, but not Ly-2.2 25). Transfer of antibody will also not convey resistance on recipients. In man there is a correlation between inflammatory responses, T lymphocyte blastogenesis and recovery. Patients with persistent foot infections (T. rubrum) or tinea corporis (T. concentricum) have reduced levels of lymphocyte blastogenesis or cytokine (eg migratory inhibitory factor) production in response to dermatophyte antigen 26, 27, 28). In chronic infections caused by T. rubrum, compared to those infections due to T. mentagrophytes for instance, there is weak lymphocyte transformation, inflammatory reactions and relapse or persistence of infection is common. healthy individuals suggests that they are either ineffective or inoperative in some patients. It has been shown that some patients with persistent dermatophytosis have defective lymphocyte blastogenesis to T-cell mitogens and dermatophyte antigen and that this can be reversed either by substituting heterologous (foetal calf) for autologous serum or after successful antif ungal treatment35).
A similar finding is seen with neutrophil responses. This suggests that an inhibitory factor (s) is present in serum and is evidence that the inhibition of lymphocyte blastogenesis by dermatophyte components may play a role in immunomodulation. The dermatophyte antigen, found in serum from infected patients, has been identified employing an immuno-radiometric assay using the mouse antidermatophyte IgM monoclonal TQ-134). Antigen derived from Trichophyton species containing TQ-1 reactive epitopes increases susceptibility of Balb/c mice to dermatophyte infection and interferes with T-cell mediated immunity (Calderon and Hay unpublished data). TQ-1 antibody reacts with phosphoryl-choline (PC) and immunoreactivity can be abrogated by pre-treatment with PC. Phosphoryl-choline hapten is found in other parasites including filaria and also affects expression of immune responses in these infections. The other different factor identified as being part of the f tingal cell wall is a high molecular weight glycoprotein. It is this that causes reversible inhibition of lymphocyte blastogenesis at certain concentrations33). It is possible that a mannose component such as has been described in C. albicans may be responsible36).
In vivo correlation
The possibility that dermatophytes interfere with the process of immunological activation in the skin is supported by observations on the presence of active molecules such as adhesion molecules in biopsies from chronically infected skin. Normally immunophenotypic techniques can demonstrate the presence of large numbers of effector lymphocytes in the vicinity of the infection37). Work has now shown that the dermal infiltrate mainly contain cells which were Leu 2a positive (viz T helper cells) 38). Conversely few expressed CD-8 (T suppressor markers). HLA-DR was strongly expressed and most biopsies showed Langerhans cells using a variety of different cell markers. Despite the presence of an infiltrate adhesion molecules, such as ICAM-1, were poorly expressed in epidermis 38). This may reflect suppression of the production of these substances in the epidermis despite intact cell mediated immunity. Suppression of this aspect of immune activation by a dermatophyte inhibitory factor (DIF) produced by fungi in situ is a possible explanation, which may account for the success of dermatophytes such as T. rubrum in causing persistent infections.
Conclusions
Although much is known about the immunological response in human dermatophytosis there are still many loose ends, particularly the relationship between atopy and infection. There is evidence from a number of studies, described above, that atopic subjects are more susceptible to persistent infections, particularly if they are not involved in occupations where exposure to infection occurs frequently. Patients with persistent infection due to T. rubrum or T. concentricum are more likely to have positive immediate type immune responses to skin testing with trichophytin and raised specific IgE 21, 27, 28). It has also been shown that this occurs with T. rubrum infections in other sites such as the groin39). It is not clear though whether it develops because of some defect in T cell responsiveness seen in atopic individuals or whether the production of specific IgE and consequent release of mediators such as histamine affect the expression of an effective immunological response40) Whatever the reason the association between atopics and an increased tendency to superficial infection by bacteria, fungi and certain viruses is now well established.
The evidence put forward in this paper suggests that during the course of dermatophytosis one reason for failure of cellular immunity and, subsequently, the emergence of chronic infection may be modification of the host's immune response by fungal antigen. At present many studies of immunoregulation in skin have concentrated on diseases such as irritant dermatitis41) and psoriasis. However a closer understanding of the pathogenesis of infections such as dermatophytosis may provide a new model for furthering our understanding of the means whereby immunological signals appear to ignored by the immune system. With C. albicans other antigens have been found to mediate immunosuppressive responses. For instance, a glycoprotein extracted with ethylene-diamine suppresses transformation of murine splenic lymphocytes to a range of mitogens and cell wall mannan can elicit a similar response which is concentration dependent42).
Antigen mediated regulatory mechanisms seen with dermatophytes are therefore likely to be shared by other human fungal pathogens and possibly other organisms as well.
